What does a physician do with a 100-biomarker lab panel you ordered yourself?

What can a large lab panel show on its own, and what can it not?

On its own, a large panel shows where each marker sits against a reference range on the day of the draw. It cannot say why a value is there, how long it has been there, or what it means for that person.

That is still useful. A broad panel can surface something nobody was looking for: low iron stores, an early shift in blood sugar regulation, thyroid antibodies, or a high level of Lp(a), an inherited cholesterol-carrying particle and one of the advanced biomarkers a standard lipid panel does not measure. It also sets a baseline for later comparison.

The limits are built into how reference ranges work. A standard range is drawn to include about 95 percent of healthy people, so every marker carries a small chance of flagging someone who is perfectly well. Across a panel those chances add up: by one calculation, a healthy person having ten independent tests has only about a 60 percent chance that every result lands inside its range, and at fifteen tests the odds fall below even [PMID: 15327009]. With a hundred markers, a few flags are expected even in someone entirely well. The opposite also holds: a value can sit inside its range and still be a real change for that person.

A single draw also carries the conditions of that morning. Fasting, the time of day, a hard workout the day before, a recent cold, the day of the menstrual cycle and supplements all move numbers. Biotin, a B vitamin common in hair and nail supplements, can distort thyroid results and other tests that rely on the same laboratory method [PMID: 40417451].

The services that sell these panels describe their own role in similar terms. As of September 2026, Function Health describes its offering as “160+ lab tests, doctor-reviewed insights, and a personalized health plan” and recommends that people with questions about their results “discuss those questions with a primary care physician or other licensed provider.” Superpower says it tests “150+ biomarkers annually across two blood draws” and that the service is “designed to complement a primary care doctor if you have one, not replace them.”

Blood test results explained: how a physician reads a large panel

A physician reads a large panel from the person outward, not from the flags inward. The history comes first, the markers are then read in clusters and against earlier results, and only after that does any single number get a meaning.

The history sets the odds. Symptoms, family history, medications and supplements, menstrual or menopausal status, alcohol, training load, sleep and recent illness all change what a given value is likely to mean. The same mildly raised inflammation marker reads one way in someone recovering from a virus and another way in someone with months of joint pain.

The markers are then read together, because most of them travel in groups:

• Blood sugar regulation. Fasting insulin, glucose, triglycerides, HDL, the liver enzyme ALT, uric acid and HbA1c, a three-month average of blood sugar, tend to shift together as the body becomes resistant to insulin, often before glucose alone looks abnormal
• Iron and blood counts. Ferritin, a protein that reflects stored iron, also rises with inflammation, so it is read beside an inflammation marker such as hs-CRP, the iron saturation and the red cell indices
• Thyroid. TSH, the brain's signal to the thyroid, means more beside free T4 and free T3, the hormones themselves, and thyroid antibodies
• Cardiovascular risk. ApoB, a count of the particles that carry cholesterol into artery walls, and Lp(a) are weighed with blood pressure, family history and sometimes imaging, not judged as isolated numbers
• Kidney and liver. Creatinine reflects muscle mass as well as kidney function, and liver enzymes rise after hard exercise as well as with fat in the liver, so neither is read alone

Earlier results matter as much as the current ones. A value that has been mildly out of range and stable for ten years, such as a slightly raised bilirubin, a pigment the liver clears, from a common and harmless inherited trait, is a different finding from the same value appearing for the first time. A value that is still inside its range but has moved steadily in one direction across three draws can deserve more attention than a flag.

The last step is the question that organizes everything else: would knowing more about this result change what happens next? If not, the finding is noted and left alone. If so, it earns a confirming test.

What usually comes next after a large panel?

Most panels sort into three groups: results that need nothing, results worth repeating under better conditions, and a small number that open a focused workup.

Repeating comes before reacting, because many markers vary from week to week within the same person. When a national survey retested adults about two and a half weeks after a first draw, more than 30 percent of those with a raised ALT, AST or bilirubin, three common liver tests, were back in the normal range [PMID: 18316753]. A repeat draw done fasting, in the morning, away from illness and hard training settles a good share of flags.

When a finding holds up, the next tests are chosen to answer one question at a time:

• A persistent shift in blood sugar markers may lead to a glucose tolerance test or a period wearing a continuous glucose sensor
• Persistently raised liver enzymes usually lead to an ultrasound or a liver stiffness scan and a review of alcohol and medications
• A high ApoB or Lp(a) leads to a fuller cardiovascular risk assessment, sometimes including a coronary calcium score, a CT scan that measures calcified plaque
• Low ferritin raises the question of why: intake, absorption or blood loss, which for some people means a gastrointestinal evaluation
• An unexpected autoimmune or cancer-related marker in a person without symptoms is usually repeated and put in context before anything else is ordered

Knowing when to stop is part of the work. In a national survey of US internists, nearly all reported having seen an unexpected finding set off a cascade of further tests, sometimes ending in something important and treatable and sometimes ending nowhere [PMID: 31617925]. Deciding which thread to pull, and staying accountable for that decision, is the clinical part of the job.

Which results need prompt attention?

A small set of results should not wait for a routine appointment. Laboratories label these critical values and phone them through, so a person may hear about one by telephone before the full report arrives.

They include a very high or very low potassium or sodium, a very high blood sugar, a very low hemoglobin or platelet count, and kidney or liver numbers many times the upper limit. A result flagged as critical, or any abnormal result that arrives alongside chest pain, trouble breathing, fainting, confusion, sudden weakness, or black or bloody stools, is a reason to seek prompt care: call 911 or go to the nearest emergency department.

Can a self-ordered panel be used in a physician's care?

Yes. Results from a service a person ordered on their own are reviewed as part of care, the same as results from any accredited laboratory. The full report is more useful than a screenshot or a summary: every marker with its units and reference range, the date and time of the draw, and whether it was fasting.

Earlier labs, even from years ago, a list of medications and supplements, and the family history make the reading sharper. So does a note of what prompted the panel, because the reason for testing shapes what the results mean. How a lab testing service and a physician-led practice fit together comes down to who does what once the results arrive.

The deeper picture

A large panel makes measuring easy and leaves interpreting hard, because the meaning of any result depends on how likely the condition was before the test was run, and that likelihood lives in the person's history, not in the report. Two errors sit on either side: chasing every flag until a well person feels unwell, and waving off a quiet trend because each value was technically in range. Avoiding both takes physician-level clinical rigor applied to a whole person, which is how results from any source are read at Extend Medical.